David Glass, MD, is the Vice President of Research at Regeneron Pharmaceuticals, Inc. Prior to joining Regeneron, he was the Executive Director of the Novartis Institutes for Biomedical Research in Cambridge, Massachusetts. He was also Vice President for Muscle Diseases at Regeneron Pharmaceuticals, where he worked for 14 years. Dr. Glass serves on both the Board of Directors and Scientific Advisory Board of the FSHD Society. He holds an MD from New York Medical College and conducted postdoctoral work at Columbia University. He is the co-author of more than 50 peer-reviewed research articles on cell signaling mechanisms in neuromuscular disease, obesity, and cancer.